GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Insider Ownership

Immunoclin (Immunoclin) Insider Ownership : 66.25 % (As of May. 25, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Immunoclin's insider ownership is 66.25%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Immunoclin's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Immunoclin's Float Percentage Of Total Shares Outstanding is 1.75%.

Immunoclin Insider Ownership Historical Data

The historical data trend for Immunoclin's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Insider Ownership Chart

Immunoclin Historical Data

The historical data trend for Immunoclin can be seen below:

2018-02-28 2018-03-31 2018-04-30 2018-05-31 2018-06-30 2018-07-31 2018-08-31 2018-09-30 2018-10-31 2018-11-30
Insider Ownership 66.25 66.25 66.25 66.25 66.25 66.25 66.25 66.25 66.25 66.25

Immunoclin Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Immunoclin (Immunoclin) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Insider Ownership
Comparable Companies
BOM:506128 ASX:ATX OSTO:ANNX IMUN ASX:FIJ ASX:FTT ATRX TSXV:THRM WAR:BLR FNAM ASX:NC6 XCNQ:VP ENLV ASX:RAC VODG TSXV:MFS OSTO:A1M XSAT:CLINE B ASX:MEB XCNQ:LILY
Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Website
http://www.immunoclin.com
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines